These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12765334)

  • 1. Schizophrenia: neural mechanisms for novel therapies.
    Sawa A; Snyder SH
    Mol Med; 2003; 9(1-2):3-9. PubMed ID: 12765334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schizophrenia drug discovery and development in an evolving era: are new drug targets fulfilling expectations?
    Dunlop J; Brandon NJ
    J Psychopharmacol; 2015 Feb; 29(2):230-8. PubMed ID: 25586401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The involvement of D-1 and D-2 dopamine receptors in the effects of neuroleptics and the pathogenesis of schizophrenia].
    Wielgosz M
    Psychiatr Pol; 1992; 26(5):357-64. PubMed ID: 1363827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The past and future of novel, non-dopamine-2 receptor therapeutics for schizophrenia: A critical and comprehensive review.
    Girgis RR; Zoghbi AW; Javitt DC; Lieberman JA
    J Psychiatr Res; 2019 Jan; 108():57-83. PubMed ID: 30055853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor mechanisms in antipsychotic drug action: focus on sigma receptors.
    Snyder SH; Largent BL
    J Neuropsychiatry Clin Neurosci; 1989; 1(1):7-15. PubMed ID: 2577720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical antipsychotics: mechanism of action.
    Seeman P
    Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function.
    Levin ED; Rezvani AH
    Biochem Pharmacol; 2007 Oct; 74(8):1182-91. PubMed ID: 17714691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine and typical antipsychotics.
    Ross DE
    Am J Psychiatry; 2004 Oct; 161(10):1925-6. PubMed ID: 15465996
    [No Abstract]   [Full Text] [Related]  

  • 10. Unmet needs in the treatment of schizophrenia: new targets to help different symptom domains.
    Citrome L
    J Clin Psychiatry; 2014; 75 Suppl 1():21-6. PubMed ID: 24581451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of dysfunctional glutamatergic transmission for the development of psychotic symptoms.
    Pietraszek M
    Pol J Pharmacol; 2003; 55(2):133-54. PubMed ID: 12926541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical neuroleptics in the treatment of early onset schizophrenia.
    Masi G
    Panminerva Med; 1997 Sep; 39(3):215-21. PubMed ID: 9360425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The newer, 'atypical' antipsychotic drugs--their development and current therapeutic use.
    Kendrick T
    Br J Gen Pract; 1999 Sep; 49(446):745-9. PubMed ID: 10756621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents.
    Miyamoto S; Miyake N; Jarskog LF; Fleischhacker WW; Lieberman JA
    Mol Psychiatry; 2012 Dec; 17(12):1206-27. PubMed ID: 22584864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The atypical neuroleptic concept].
    Azorin JM; Dassa D; Jalfre M
    Encephale; 1992 Sep; 18 Spec No 3():453-7. PubMed ID: 1364079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic treatment of schizophrenia.
    Levinson DF
    Clin Ther; 1991; 13(3):326-52. PubMed ID: 1683269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamatergic neurotransmission modulation and the mechanisms of antipsychotic atypicality.
    Heresco-Levy U
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1113-23. PubMed ID: 14642971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine D4 receptors: a new opportunity for research on schizophrenia.
    Liégeois J; Eyrolles L; Bruhwyler J; Delarge J
    Curr Med Chem; 1998 Apr; 5(2):77-100. PubMed ID: 9481035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Receptor polymorphism and response to treatment in schizophrenia].
    Szekeres G; Janka Z
    Orv Hetil; 2002 Sep; 143(35):2027-33. PubMed ID: 12387196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurobiological background for the development of new drugs in schizophrenia.
    López-Muñoz F; Álamo C
    Clin Neuropharmacol; 2011; 34(3):111-26. PubMed ID: 21586917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.